389 related articles for article (PubMed ID: 20510763)
1. Innovative use of topical calcineurin inhibitors.
Lin AN
Dermatol Clin; 2010 Jul; 28(3):535-45. PubMed ID: 20510763
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of topical calcineurin inhibitors in vitiligo.
Wong R; Lin AN
Int J Dermatol; 2013 Apr; 52(4):491-6. PubMed ID: 23331250
[TBL] [Abstract][Full Text] [Related]
3. Potential new indications of topical calcineurin inhibitors.
Luger T; Paul C
Dermatology; 2007; 215 Suppl 1():45-54. PubMed ID: 18174692
[TBL] [Abstract][Full Text] [Related]
4. Topical pimecrolimus for skin disease other than atopic dermatitis.
Wollina U; Hansel G; Koch A; Abdel-Naser MB
Expert Opin Pharmacother; 2006 Oct; 7(14):1967-75. PubMed ID: 17020422
[TBL] [Abstract][Full Text] [Related]
5. Use of pimecrolimus cream in disorders other than atopic dermatitis.
Day I; Lin AN
J Cutan Med Surg; 2008; 12(1):17-26. PubMed ID: 18258153
[TBL] [Abstract][Full Text] [Related]
6. Off-label Uses of Topical Pimecrolimus.
Ladda M; Sandhu V; Ighani A; Yeung J
J Cutan Med Surg; 2019; 23(4):442-448. PubMed ID: 31053034
[TBL] [Abstract][Full Text] [Related]
7. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.
Stinco G; Piccirillo F; Forcione M; Valent F; Patrone P
Eur J Dermatol; 2009; 19(6):588-93. PubMed ID: 19651562
[TBL] [Abstract][Full Text] [Related]
8. Topical calcineurin inhibitors for the treatment of vulvar dermatoses.
Goldstein AT; Thaçi D; Luger T
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):22-9. PubMed ID: 19631446
[TBL] [Abstract][Full Text] [Related]
9. The use of topical tacrolimus and pimecrolimus to treat psoriasis: a review.
Scheinfeld N
Dermatol Online J; 2004 Jul; 10(1):3. PubMed ID: 15347485
[TBL] [Abstract][Full Text] [Related]
10. Association between exposure to topical tacrolimus or pimecrolimus and cancers.
Hui RL; Lide W; Chan J; Schottinger J; Yoshinaga M; Millares M
Ann Pharmacother; 2009 Dec; 43(12):1956-63. PubMed ID: 19903860
[TBL] [Abstract][Full Text] [Related]
11. Pimecrolimus cream 1% in erosive oral lichen planus--a prospective randomized double-blind vehicle-controlled study.
Volz T; Caroli U; Lüdtke H; Bräutigam M; Kohler-Späth H; Röcken M; Biedermann T
Br J Dermatol; 2008 Sep; 159(4):936-41. PubMed ID: 18647310
[TBL] [Abstract][Full Text] [Related]
12. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption.
Chu CY
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):484-90. PubMed ID: 17373975
[TBL] [Abstract][Full Text] [Related]
13. Safety and tolerability of 1% pimecrolimus cream among infants: experience with 1133 patients treated for up to 2 years.
Paul C; Cork M; Rossi AB; Papp KA; Barbier N; de Prost Y
Pediatrics; 2006 Jan; 117(1):e118-28. PubMed ID: 16361223
[TBL] [Abstract][Full Text] [Related]
14. Pimecrolimus 1% cream in the treatment of facial psoriasis: a 16-week open-label study.
Jacobi A; Braeutigam M; Mahler V; Schultz E; Hertl M
Dermatology; 2008; 216(2):133-6. PubMed ID: 18216475
[TBL] [Abstract][Full Text] [Related]
15. Pimecrolimus in dermatology: atopic dermatitis and beyond.
Gisondi P; Ellis CN; Girolomoni G
Int J Clin Pract; 2005 Aug; 59(8):969-74. PubMed ID: 16033622
[TBL] [Abstract][Full Text] [Related]
16. Topical treatment and combination approaches for vitiligo: new insights, new developments.
Hossani-Madani AR; Halder RM
G Ital Dermatol Venereol; 2010 Feb; 145(1):57-78. PubMed ID: 20197746
[TBL] [Abstract][Full Text] [Related]
17. Pimecrolimus in dermatology.
Fabroni C; Lotti T
G Ital Dermatol Venereol; 2009 Jun; 144(3):321-5. PubMed ID: 19528913
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of topical calcineurin inhibitors in lichen planus.
Samycia M; Lin AN
J Cutan Med Surg; 2012; 16(4):221-9. PubMed ID: 22784514
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison.
Draelos Z; Nayak A; Pariser D; Shupack JL; Chon K; Abrams B; Paul CF
J Am Acad Dermatol; 2005 Oct; 53(4):602-9. PubMed ID: 16198779
[TBL] [Abstract][Full Text] [Related]
20. Pimecrolimus 1% cream for oral erosive lichen planus: a 6-week randomized, double-blind, vehicle-controlled study with a 6-week open-label extension to assess efficacy and safety.
McCaughey C; Machan M; Bennett R; Zone JJ; Hull CM
J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1061-7. PubMed ID: 21175873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
